title: Descriptive epidemiology of affective disorders in multiple sclerosis.
abstract: BACKGROUND
  Affective disorders present an important clinical challenge in multiple sclerosis (MS). Due to prohibitive sample size requirements, population-based studies have not yet provided an adequate description of the underlying epidemiology of this association.
  
  
  OBJECTIVE
  To describe the epidemiology of affective disorders in MS in a general population sample.
  
  
  METHODS
  The study presented here accessed administrative data from a universal healthcare insurance plan in the Canadian province of Alberta. Physician billing data recorded in the Alberta Health Care Insurance Plan was used to identify members of the population >15 years of age with and without MS. Crude and stratified estimates of the association between affective disorders and MS were made. Logistic regression analysis was used to evaluate statistical interactions and to provide adjusted estimates of the association.
  
  
  RESULTS
  The estimated prevalence of MS in the population within the targeted age range (2.3 million individuals) was 386/100,000 and that of affective disorders was 7.7%. As expected, an association between MS and affective disorders was identified (crude relative prevalence: 2.2). The association varied in strength over age-sex categories. Although the prevalence of affective disorder was higher in women with MS than men with MS, the association of MS with affective disorders was stronger in men. The strength of association declined with age in both men and women. Affective disorder prevalence in people with MS becomes similar to that of the general population in older age groups.
  
  
  CONCLUSIONS
  Affective disorders occur with an increased frequency in MS. This is true in men and women and across all relevant age groups, although the association gets weaker with advancing age. Higher frequencies of affective disorder occur in women with MS than in men with MS. The frequency of affective disorder in people with MS is highest in the 25-44 age group, and declines in older age categories.
authors.affiliation: Department of Community Health Sciences, Faculty of Medicine, University of Calgary, Canada.
authors.forename: Scott B
authors.initials: SB
authors.lastname: Patten
authors.forename: Lawrence W
authors.initials: LW
authors.lastname: Svenson
authors.forename: Luanne M
authors.initials: LM
authors.lastname: Metz
mesh_terms: D000293:Adolescent; D000328:Adult; D002170:Canada / Q000453:epidemiology; D002391:Catchment Area, Health; D005260:Female; D006801:Humans; D038801:International Classification of Diseases; D008297:Male; D008875:Middle Aged; D019964:Mood Disorders / Q000175:diagnosis / Q000453:epidemiology*; D009103:Multiple Sclerosis / Q000453:epidemiology*; D020380:Needs Assessment; D011159:Population Surveillance